Skip to search formSkip to main contentSkip to account menu

bimoclomol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Neurodegenerative diseases (NDDs) such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease (HD), amyotrophic… 
Highly Cited
2006
Highly Cited
2006
  • M. Mccarty
  • Medical hypotheses
  • 2006
  • Corpus ID: 25235526
Highly Cited
2003
Highly Cited
2003
The hydroxylamine derivative bimoclomol (BM) has been shown to activate natural cytoprotective homeostatic responses by enhancing… 
Highly Cited
2003
Highly Cited
2003
Highly Cited
2002
Highly Cited
2002
Abstract: Bimoclomol (BML), a symptomatic antidiabetic agent, has been developed by Biorex R & D Co. to treat diabetic neuropathy… 
Review
2001
Review
2001
Bimoclomol, the recently developed non-toxic heat shock protein (HSP) coinducer, was shown to display multilateral protective… 
Highly Cited
2001
Highly Cited
2001
All cells, from bacterial to human, have a common, intricate response to stress that protects them from injury. Heat shock… 
1999
1999
Abstract. Concentration-dependent effects of bimoclomol, a novel heat shock protein (HSP) coinducer, were studied on the… 
1998
1998
A silent process involving both neural and vascular structures in diabetic retina persists for several years before clinically… 
Highly Cited
1997
Highly Cited
1997
Preservation of the chemical architecture of a cell or of an organism under changing and perhaps stressful conditions is termed…